Cargando…

Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study

Research Question: Does treatment with tocilizumab increase the risk of a fungal infection in critically ill patients with coronavirus-19? Background: Numerous therapies have been evaluated as possible treatments for coronavirus-2019 caused by severe acute respiratory syndrome coronavirus-2. Tociliz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burger, Barrett J., Epps, Sarenthia M., Cardenas, Victor M., Jagana, Rajani, Meena, Nikhil K., Atchley, William T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455962/ https://www.ncbi.nlm.nih.gov/pubmed/37629609 http://dx.doi.org/10.3390/life13081752

Ejemplares similares

Personal Protective Equipment Efficiency in Healthcare Emergencies: A Single-Center Experience
por: Goraya, Harmeen, et al.
Publicado: (2022)

Tocilizumab in critically ill COVID-19 patients: An observational study
por: Mushtaq, Muhammad Z., et al.
Publicado: (2022)

TWO CASES OF ARTERIAL THROMBUS IN COVID-19 INFECTION
por: EPPS, SARENTHIA, et al.
Publicado: (2021)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

Tocilizumab treatment in critically ill patients with COVID-19: A retrospective observational study
por: Huang, Edmund, et al.
Publicado: (2021)

Copeptin and acute renal failure in critically ill patients
por: Meyer, B, et al.
Publicado: (2008)

Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients
por: Bhandari, Sudhir, et al.
Publicado: (2021)

A Rare Case of Pulmonary Emboli Presenting With ST Elevation on ECG
por: Gheith, Zaid, et al.
Publicado: (2022)

IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome
por: Dufranc, Etienne, et al.
Publicado: (2020)

The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
por: Zacharias, Harry, et al.
Publicado: (2022)

Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
por: Camou, Fabrice, et al.
Publicado: (2022)

Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19
por: Szabo, Robert, et al.
Publicado: (2023)

Fungal colonization and infection in critically ill patients
por: Lorente, L, et al.
Publicado: (2005)

Tocilizumab Outcomes in Critically Ill COVID-19 Patients Admitted to the ICU and the Role of Non-Tocilizumab COVID-19-Specific Medical Therapeutics
por: Elhazmi, Alyaa, et al.
Publicado: (2023)

Acute renal failure in critically ill HIV-infected patients
por: Lopes, José António, et al.
Publicado: (2007)

Bone resorption and acute renal failure in the hypercalcaemic critically ill
por: Ledson, JF, et al.
Publicado: (2001)

IVC Measurements in Critically Ill Patients with Acute Renal Failure
por: Jambeih, Rami, et al.
Publicado: (2017)

A Rare Cause of Pulmonary Edema in the Postoperative Period
por: Chatterjee, Kshitij, et al.
Publicado: (2017)

Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis
por: Rajendram, Prabalini, et al.
Publicado: (2021)

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2
por: Petrak, Russell M., et al.
Publicado: (2021)

Acute renal failure requiring dialysis in very old critically ill patients
por: Espinoza, M, et al.
Publicado: (2004)

Serum soluble-Fas, inflammation and anemia in acute renal failure and critical illness
por: Góes, MA, et al.
Publicado: (2011)

Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study
por: Hafez, Wael, et al.
Publicado: (2022)

Pharmacokinetics of antituberculosis drugs in critically ill patients with tuberculosis and acute respiratory failure
por: Hernandez-Cardenas, CH, et al.
Publicado: (2014)

Renal failure in critically ill patients, beware of applying (central venous) pressure on the kidney
por: Chen, Xiukai, et al.
Publicado: (2018)

Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
por: ElSeirafi, Mohamed M, et al.
Publicado: (2020)

Outcome from acute renal failure complicating critical illness is influenced by age
por: Garfield, MJ, et al.
Publicado: (2003)

Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series
por: Mady, Ahmed, et al.
Publicado: (2020)

Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in “non-critically-ill” patients on hemodialysis
por: Castellano, Giuseppe, et al.
Publicado: (2020)

The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study
por: Korayem, Ghazwa B., et al.
Publicado: (2022)

Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review
por: Corona, Alberto, et al.
Publicado: (2022)

Methylprednisolone/tocilizumab: Fungal sepsis and pseudomonal pneumonia: 2 case reports
Publicado: (2021)

Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report
por: Huang, Thomas Tao-Min, et al.
Publicado: (2021)

An assessment of the RIFLE criteria for acute renal failure in critically ill HIV-infected patients
por: Lopes, José António, et al.
Publicado: (2007)

Acute renal failure prolongs weaning from mechanical ventilation in critically ill patients
por: Vieira, J, et al.
Publicado: (2006)

Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients
por: Cala-García, Juan David, et al.
Publicado: (2020)

Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers
por: Atallah, Bassam, et al.
Publicado: (2020)

What's New in Critical Illness and Injury Science? Mortality effects of tocilizumab for patients admitted with COVID-19 pneumonia
por: Miller, Andrew C., et al.
Publicado: (2021)

Acute Thyrotoxic Bulbar Myopathy with Encephalopathic Behaviour: An Uncommon Complication of Hyperthyroidism
por: Boddu, Neeraja J., et al.
Publicado: (2013)

Bacterial and fungal superinfections in critically ill patients with COVID-19
por: Bassetti, Matteo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gdrsm4qlnodanelocpegs3l072